Full Text View
Tabular View
No Study Results Posted
Related Studies
Phase I Study of DOXIL and Temsirolimus in Resistant Solid Malignancies
This study is ongoing, but not recruiting participants.
Study NCT00703170   Information provided by Washington University School of Medicine
First Received: June 20, 2008   Last Updated: September 15, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Resistant Solid Malignancies
Additional conditions recognized in this trial
Neoplasms
Additional drug interventions recognized in this trial
Doxorubicin
Sirolimus
More general drug interventions related to this trial
Anti-Bacterial Agents
Anti-Infective Agents
Antibiotics, Antineoplastic
Antifungal Agents
Antineoplastic Agents
Immunologic Factors
Immunosuppressive Agents
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
Washington University School of Medicine


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services